Yong Huang

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management
    Yong Huang
    Drug Studies Unit, Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California, San Francisco, CA 94143 0446, USA
    Bioanalysis 4:1919-31. 2012
  2. ncbi Matrix effect and recovery terminology issues in regulated drug bioanalysis
    Yong Huang
    Drug Studies Unit, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143, USA
    Bioanalysis 4:271-9. 2012
  3. ncbi Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry
    Yong Huang
    Department of Biopharmaceutical Sciences, University of California, San Francisco, CA 94143, USA
    Rapid Commun Mass Spectrom 22:3401-9. 2008
  4. ncbi Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry
    Yong Huang
    Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143, USA
    Anal Bioanal Chem 401:1923-33. 2011
  5. ncbi A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women
    Monica Gandhi
    Department of Medicine, University of California, San Francisco, CA, USA
    J Infect Dis 206:1453-61. 2012
  6. ncbi Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy
    Monica Gandhi
    Departments of Medicine, University of California, San Francisco, 94122, USA
    Clin Infect Dis 52:1267-75. 2011
  7. ncbi Protease inhibitor levels in hair strongly predict virologic response to treatment
    Monica Gandhi
    Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    AIDS 23:471-8. 2009
  8. ncbi Ligand-mediated activation of an engineered gs g protein-coupled receptor in osteoblasts increases trabecular bone formation
    Edward C Hsiao
    Gladstone Institute of Cardiovascular Disease, 1650 Owens Street, San Francisco, California 94158, USA
    Mol Endocrinol 24:621-31. 2010
  9. ncbi 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone
    Thomas S Scanlan
    Department of Pharmaceutical Chemistry and Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California 94143 2280, USA
    Nat Med 10:638-42. 2004
  10. ncbi Pharmacokinetics of quinacrine efflux from mouse brain via the P-glycoprotein efflux transporter
    Misol Ahn
    Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, California, USA
    PLoS ONE 7:e39112. 2012

Collaborators

Detail Information

Publications20

  1. ncbi Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management
    Yong Huang
    Drug Studies Unit, Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California, San Francisco, CA 94143 0446, USA
    Bioanalysis 4:1919-31. 2012
    ..Fostering interaction between bioanalysts from pharmaceutical science and clinical chemistry and reducing the regulatory gaps between different agencies for drug bioanalysis is our objective...
  2. ncbi Matrix effect and recovery terminology issues in regulated drug bioanalysis
    Yong Huang
    Drug Studies Unit, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143, USA
    Bioanalysis 4:271-9. 2012
    ..We also provide our personal views on the term 'recovery'...
  3. ncbi Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry
    Yong Huang
    Department of Biopharmaceutical Sciences, University of California, San Francisco, CA 94143, USA
    Rapid Commun Mass Spectrom 22:3401-9. 2008
    ..This developed method allowed for the monitoring of these target medications in the hair samples of HIV-infected women on antiretroviral therapy in an observational study using small amounts of hair...
  4. ncbi Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry
    Yong Huang
    Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143, USA
    Anal Bioanal Chem 401:1923-33. 2011
    ..We also showed that NVP in human hair can easily be detected in a single short strand of hair. This method will allow us to identify drug non-adherence using even a single strand of hair...
  5. ncbi A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women
    Monica Gandhi
    Department of Medicine, University of California, San Francisco, CA, USA
    J Infect Dis 206:1453-61. 2012
    ..We analyzed numerous genetic and nongenetic factors impacting short-term and long-term exposure in a large heterogeneous population of human immunodeficiency virus (HIV)-infected women...
  6. ncbi Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy
    Monica Gandhi
    Departments of Medicine, University of California, San Francisco, 94122, USA
    Clin Infect Dis 52:1267-75. 2011
    ..Hair concentrations of antiretrovirals can integrate adherence and pharmacokinetics into a single assay...
  7. ncbi Protease inhibitor levels in hair strongly predict virologic response to treatment
    Monica Gandhi
    Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    AIDS 23:471-8. 2009
    ..The currently available methods to assess ARV exposure are limited. Levels of ARVs in hair reflect plasma concentrations over weeks to months, and may provide a novel method for predicting therapeutic responses...
  8. ncbi Ligand-mediated activation of an engineered gs g protein-coupled receptor in osteoblasts increases trabecular bone formation
    Edward C Hsiao
    Gladstone Institute of Cardiovascular Disease, 1650 Owens Street, San Francisco, California 94158, USA
    Mol Endocrinol 24:621-31. 2010
    ..This model provides a powerful tool for investigating the effects of ligand-activated G(s)-GPCR signaling on dynamic bone growth and remodeling...
  9. ncbi 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone
    Thomas S Scanlan
    Department of Pharmaceutical Chemistry and Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California 94143 2280, USA
    Nat Med 10:638-42. 2004
    ..These results suggest the existence of a new signaling pathway, stimulation of which leads to rapid physiological and behavioral consequences that are opposite those associated with excess TH...
  10. ncbi Pharmacokinetics of quinacrine efflux from mouse brain via the P-glycoprotein efflux transporter
    Misol Ahn
    Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, California, USA
    PLoS ONE 7:e39112. 2012
    ..Our findings argue that the inhibition of the P-gp efflux transporter should improve the poor pharmacokinetic properties of quinacrine in the CNS...
  11. ncbi Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease
    David Favre
    Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, CA 94110, USA
    Sci Transl Med 2:32ra36. 2010
    ..We postulate that induction of IDO may represent a critical initiating event that results in inversion of the T(H)17/T(reg) balance and in the consequent maintenance of a chronic inflammatory state in progressive HIV disease...
  12. ncbi Y-27632 improves rotarod performance and reduces huntingtin levels in R6/2 mice
    Mei Li
    Department of Neurology, University of California, San Francisco, CA 94143, USA
    Neurobiol Dis 36:413-20. 2009
    ..However, Y-27632 treatment improved rotarod performance significantly, and also reduced soluble brain Htt levels. The ROCK signaling pathway thus remains a promising therapeutic target for HD, and more potent inhibitors may prove useful...
  13. ncbi Distinctive T cell-suppressive signals from nuclearized type 1 sphingosine 1-phosphate G protein-coupled receptors
    Jia Jun Liao
    Department of Medicine, University of California, San Francisco, California 94143, USA
    J Biol Chem 282:1964-72. 2007
    ....
  14. ncbi Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate
    Rajita Pappu
    Cardiovascular Research Institute, University of California, San Francisco, 600 16th Street S472D, San Francisco, CA 94143 2240, USA
    Science 316:295-8. 2007
    ..Disruption of compartmentalized S1P signaling is a plausible mechanism by which S1P-receptor-1 agonists function as immunosuppressives...
  15. ncbi Non-competitive androgen receptor inhibition in vitro and in vivo
    Jeremy O Jones
    Department of Neurology, University of California San Francisco, San Francisco, CA 94115, USA
    Proc Natl Acad Sci U S A 106:7233-8. 2009
    ..Pyrvinium inhibits AR-dependent gene expression in the prostate gland in vivo, and induces prostate atrophy. These results highlight new therapeutic strategies to inhibit AR activity...
  16. ncbi In vitro and in vivo correlation of hepatic transporter effects on erythromycin metabolism: characterizing the importance of transporter-enzyme interplay
    Justine L Lam
    Professor, Department of Biopharmaceutical Sciences, University of California San Francisco, 533 Parnassus, Room U-68, San Francisco, CA 94143-0446, USA
    Drug Metab Dispos 34:1336-44. 2006
    ..Hepatic uptake and efflux transporters modulate intracellular concentrations of ERY, thereby affecting metabolism. The interplay of transporters and enzymes must be considered in evaluating potential drug-drug interactions...
  17. ncbi Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation
    Chanhung Z Lee
    Department of Anesthesia and Perioperative Care, University of California, San Francisco, 94110, USA
    J Cereb Blood Flow Metab 26:1157-64. 2006
    ..This study provided the evidence that the tetracyclines inhibit stimulated cerebral MMP-9 at multiple levels and are effective at very low doses, offering great potential for therapeutic use...
  18. ncbi Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients
    Susan R Schwab
    Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 0414, USA
    Science 309:1735-9. 2005
    ..We conclude that lymphocyte egress is mediated by S1P gradients that are established by S1P lyase activity and that the lyase may represent a novel immunosuppressant drug target...
  19. ncbi Effects of uremic toxins on hepatic uptake and metabolism of erythromycin
    Hong Sun
    Department of Biopharmaceutical Sciences, University of California, San Francisco, California 94143-0446, USA
    Drug Metab Dispos 32:1239-46. 2004
    ..Our results suggest that CMPF can directly inhibit the uptake of Ery by inhibiting Oatp2, whereas IS is more likely to inhibit the enzymatic metabolism of Ery...
  20. ncbi Liquid chromatographic-tandem mass spectrometric assay for the simultaneous determination of didanosine and stavudine in human plasma, bronchoalveolar lavage fluid, alveolar cells, peripheral blood mononuclear cells, seminal plasma, cerebrospinal fluid an
    Yong Huang
    Department of Biopharmaceutical Sciences, University of California San Francisco, 94117, San Francisco, CA, USA
    J Chromatogr B Analyt Technol Biomed Life Sci 799:51-61. 2004
    ..The lower limits of quantitation for both ddI and d4T were 2.0 ng/ml in plasma; 0.5 ng/ml in CSF; 0.4 ng/ml in AC, PBMC, and BALF; 1.0 ng/ml in seminal plasma; and 0.01 ng/mg in tonsil tissue...